Sotera Health Co
Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and e… Read more
Sotera Health Co (SHC) - Net Assets
Latest net assets as of September 2025: $550.47 Million USD
Based on the latest financial reports, Sotera Health Co (SHC) has net assets worth $550.47 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.19 Billion) and total liabilities ($2.64 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $550.47 Million |
| % of Total Assets | 17.28% |
| Annual Growth Rate | 43.95% |
| 5-Year Change | -10.93% |
| 10-Year Change | N/A |
| Growth Volatility | 604.94 |
Sotera Health Co - Net Assets Trend (2018–2024)
This chart illustrates how Sotera Health Co's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sotera Health Co (2018–2024)
The table below shows the annual net assets of Sotera Health Co from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $404.91 Million | -8.75% |
| 2023-12-31 | $443.73 Million | +26.69% |
| 2022-12-31 | $350.24 Million | -40.24% |
| 2021-12-31 | $586.10 Million | +28.93% |
| 2020-12-31 | $454.57 Million | +170.90% |
| 2019-12-31 | $-641.13 Million | -1509.36% |
| 2018-12-31 | $45.49 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sotera Health Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 59962500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.86 Million | 0.71% |
| Other Comprehensive Income | $-208.25 Million | -51.43% |
| Other Components | $1.22 Billion | 301.39% |
| Total Equity | $404.91 Million | 100.00% |
Sotera Health Co Competitors by Market Cap
The table below lists competitors of Sotera Health Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cactus Inc
NYSE:WHD
|
$2.72 Billion |
|
Nh Investment And Securities 1p
KO:005945
|
$2.72 Billion |
|
Danieli & C. Officine Meccaniche S.p.A
F:DAS
|
$2.72 Billion |
|
Heartland Financial USA Inc
NASDAQ:HTLF
|
$2.72 Billion |
|
Lepu Medical Tech Beijing
SHE:300003
|
$2.71 Billion |
|
MGE Energy Inc
NASDAQ:MGEE
|
$2.71 Billion |
|
SHREE CEMENT LIMITED
NSE:SHREECEM
|
$2.71 Billion |
|
SL Green Realty Corp
NYSE:SLG
|
$2.71 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sotera Health Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 443,734,000 to 404,911,000, a change of -38,823,000 (-8.7%).
- Net income of 44,398,000 contributed positively to equity growth.
- Share repurchases of 4,428,000 reduced equity.
- Other comprehensive income decreased equity by 115,569,000.
- Other factors increased equity by 36,776,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $44.40 Million | +10.96% |
| Share Repurchases | $4.43 Million | -1.09% |
| Other Comprehensive Income | $-115.57 Million | -28.54% |
| Other Changes | $36.78 Million | +9.08% |
| Total Change | $- | -8.75% |
Book Value vs Market Value Analysis
This analysis compares Sotera Health Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.75x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 76.85x to 9.75x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $0.18 | $13.85 | x |
| 2019-12-31 | $-2.26 | $13.85 | x |
| 2020-12-31 | $1.60 | $13.85 | x |
| 2021-12-31 | $2.10 | $13.85 | x |
| 2022-12-31 | $1.25 | $13.85 | x |
| 2023-12-31 | $1.57 | $13.85 | x |
| 2024-12-31 | $1.42 | $13.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sotera Health Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.96%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.03%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 7.59x
- Recent ROE (10.96%) is above the historical average (-6.57%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -13.23% | -0.79% | 0.28x | 61.06x | $-10.31 Million |
| 2019 | 0.00% | -2.68% | 0.30x | 0.00x | $43.41 Million |
| 2020 | -8.54% | -4.72% | 0.30x | 6.10x | $-83.85 Million |
| 2021 | 19.94% | 12.55% | 0.33x | 4.76x | $58.27 Million |
| 2022 | -66.69% | -23.27% | 0.32x | 8.90x | $-268.59 Million |
| 2023 | 11.58% | 4.90% | 0.34x | 7.05x | $7.00 Million |
| 2024 | 10.96% | 4.03% | 0.36x | 7.59x | $3.91 Million |
Industry Comparison
This section compares Sotera Health Co's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sotera Health Co (SHC) | $550.47 Million | -13.23% | 4.79x | $2.71 Billion |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |